Better mental wellbeing substantially reduces the risk of developing irritable bowel syndrome (IBS), with effects that are independent of genetic predisposition and partly mediated through lower depression and anxiety. In this prospective UK Biobank cohort of 75,842 IBS-free participants followed for 12.4 years, 1,400 incident IBS cases occurred, and higher […]
Findings of a UK clinical trial support the use of the Mediterranean diet (MD) as a first-line therapy for irritable bowel syndrome (IBS). A total of 139 adults with IBS (mean age 40.4 years; 80% women) from across the UK were randomized to follow either the MD (n = 68) […]
Cognitive Behavioral Therapy (CBT) has been shown to be effective in managing Irritable Bowel Syndrome (IBS) by addressing the connection between the gut and the brain. Following are some available programs: Mahana IBS (FDA-Approved): A clinically validated, prescription 3-month digital therapy program designed to reduce the severity of IBS symptoms. […]
An UK randomized trial revealed that traditional dietary advice (TDA), low FODMAP diet (LFD) and gluten-free diet (GFD) are all effective approaches in non-constipated irritable bowel syndrome (IBS), but TDA is the most patient-friendly in terms of cost and convenience. A total of 99 patients with non-constipated IBS completed the […]
A multicenter randomized controlled trial in the Netherlands showed that both individual and group hypnotherapy were effective in irritable bowel syndrome (IBS). Between May 31, 2011, and April 6, 2016, 354 patients with IBS (aged 18–65 years) were randomly allocated (3:3:1) to three groups to receive six sessions of individual […]